Mesoblast files Form 6-K with ASX press release

Mesoblast Limited submitted a Form 6-K as a foreign private issuer to provide U.S. investors with information simultaneously released in its home market.

Accepted by SEC EDGAR 09/15/2025 - 07:48 AM EDT

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

6-K

Rhea-AI Filing Summary

Mesoblast Limited submitted a Form 6-K as a foreign private issuer to provide U.S. investors with information simultaneously released in its home market. On September 15, 2025, the company filed a news release with the Australian Securities Exchange, which is attached to this report as Exhibit 99.1 and incorporated by reference.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Mesoblast Limited (MEOBF) file on Form 6-K?

Mesoblast Limited filed a Form 6-K to furnish a news release it lodged with the Australian Securities Exchange. The release is attached as Exhibit 99.1 and is incorporated by reference for U.S. investors.

When was Mesoblast Limited’s ASX news release furnished on Form 6-K?

The ASX news release was filed with the Australian Securities Exchange and furnished to U.S. investors on Form 6-K dated September 15, 2025, with the release itself also dated September 15, 2025.

What document is attached to Mesoblast (MEOBF) Form 6-K as Exhibit 99.1?

Exhibit 99.1 to the Form 6-K is a press release of Mesoblast Limited dated September 15, 2025. The Form 6-K states that this news release was filed with the Australian Securities Exchange.

Why does Mesoblast Limited (MEOBF) use Form 6-K?

Mesoblast uses Form 6-K as a foreign private issuer to make in the United States the same material information it provides in its home market. Here, it forwards an ASX news release as Exhibit 99.1.

Who signed Mesoblast Limited’s September 2025 Form 6-K?

The Form 6-K was signed on behalf of Mesoblast Limited by Company Secretary Paul Hughes. His electronic signature appears as “/s/ Paul Hughes” and the document is dated September 15, 2025.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 6-K: How Foreign Companies Report to the SEC →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Form 6-K

Report of Foreign Private Issuer
Pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934

For the month of September 2025

Commission File Number 001-37626

Mesoblast Limited

(Exact name of Registrant as specified in its charter)

Not Applicable

(Translation of Registrant’s name into English)

Australia
(Jurisdiction of incorporation or organization)

Silviu Itescu

Chief Executive Officer and Executive Director

Level 38

55 Collins Street

Melbourne 3000

Australia

(Address of principal executive offices)

Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F:

Form 20-F ☑ Form 40-F ☐

INFORMATION CONTAINED ON THIS REPORT ON FORM 6-K

On September 15, 2025, Mesoblast Limited filed with the Australian Securities Exchange a new release announcement, which is attached hereto as Exhibit 99.1, and is incorporated herein by reference.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly organized.

Mesoblast Limited

/s/ Paul Hughes

Paul Hughes

Company Secretary

Dated: September 15, 2025

INDEX TO EXHIBITS



Item

99.1						Press release of Mesoblast Ltd, dated September 15, 2025.

Source: View Original Filing on SEC EDGAR